Glenmark Pharmaceuticals and Ichnos Sciences have formed an alliance called Ichnos Glenmark Innovation (IGI) to accelerate cancer drug discovery. The alliance combines Glenmark's expertise in small molecules with Ichnos' proficiency in novel biologics. They are developing therapy solutions for hematological malignancies and solid tumors, with three innovative oncology molecules currently in clinical trials.
